Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Machatha Stephen
Chief Development Officer at Aldeyra Therapeutics. Filing since 11 Mar 2024.
CIK 0001836354
Company
Date
Role
Action
Shares
Amount
Of holding
ALDX
Aldeyra Therapeutics, Inc.
11 Aug 2025
Chief Development Officer
Sold at will
22,073
$113.71K
9.1%
ALDX
Aldeyra Therapeutics, Inc.
12 Aug 2024
Chief Development Officer
Sold at will
16,041
$75.97K
6.3%
ALDX
Aldeyra Therapeutics, Inc.
12 Mar 2024
Chief Development Officer
Sold at will
11,537
$36.50K
4.5%
ALDX
Aldeyra Therapeutics, Inc.
11 Mar 2024
Chief Development Officer
Sold at will
18,231
$62.10K
6.7%
4 decisions on file.
